Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study

Author:

Kudo Masatoshi1,Lencioni Riccardo2,Marrero Jorge A.3,Venook Alan P.4,Bronowicki Jean-Pierre5,Chen Xiao-Ping6,Dagher Lucy7,Furuse Junji8,Geschwind Jean-Francois H.9,Ladrón de Guevara Laura10,Papandreou Christos11,Sanyal Arun J.12,Takayama Tadatoshi13,Yoon Seung Kew14,Nakajima Keiko15,Lehr Robert16,Heldner Stephanie17,Ye Sheng-Long18

Affiliation:

1. Department of Gastroenterology and Hepatology; Kinki University School of Medicine; Osaka Japan

2. Division of Diagnostic Imaging and Intervention; Pisa University Hospital and School of Medicine; Pisa Italy

3. Division of Digestive and Liver Diseases; Department of Internal Medicine; University of Texas Southwestern Medical Center; Dallas TX USA

4. University of California; San Francisco CA USA

5. Department of Gastroenterology and Hepatology; INSERM U954; University Hospital; University of Lorraine; Nancy France

6. Hepatic Surgery Center; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China

7. Policlínica Metropolitana; Caracas Venezuela

8. Kyorin University School of Medicine; Tokyo Japan

9. Vascular and Interventional Radiology; Johns Hopkins University School of Medicine; Baltimore MD USA

10. Hospital Angeles Clínica Londres; Mexico City Mexico

11. University Hospital of Larissa; Larissa Greece

12. Virginia Commonwealth University Medical Center; Richmond VA USA

13. Department of Digestive Surgery; Nihon University School of Medicine; Tokyo Japan

14. The Catholic University of Korea; Seoul Korea

15. Global Medical Affairs; Bayer HealthCare Pharmaceuticals; Whippany NJ USA

16. Clinical Statistics; Bayer HealthCare Pharmaceuticals; Whippany NJ USA

17. Global Medical Affairs and Pharmacovigilance; Bayer Pharma AG; Berlin Germany

18. Liver Cancer Institute and Zhongshan Hospital; Fudan University; Shanghai China

Funder

Bayer HealthCare Pharmaceuticals

Onyx Pharmaceuticals

Amgen

Publisher

Wiley

Subject

Hepatology

Reference20 articles.

1. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma];Maillard;Cancer Radiother,2011

2. Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics;Flores;Clin Med Insights Oncol,2014

3. Risk factors of hepatocellular carcinoma - current status and perspectives;Gao;Asian Pac J Cancer Prev,2012

4. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

5. Ferlay J Soerjomataram I Ervik M et al GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 http://globocan.iarc.fr

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3